Business Description
The Cooper Companies Inc
NAICS : 339115
SIC : 3851
ISIN : US2166484020
Share Class Description:
FRA:CP60: Ordinary SharesTotal Employee Number:
15,000Description
The Cooper Companies, Inc. is a US-based medical device company operating through two segments: CooperVision and CooperSurgical. CooperVision develops, manufactures, and markets soft contact lenses, including spherical, toric, and multifocal designs, along with specialty and myopia management lenses, sold under brands such as Biofinity, MyDay, Clariti, and MiSight. CooperSurgical supplies fertility and women's health products, including IVF devices, diagnostic equipment, and medical instruments used across the reproductive care cycle. The company sells primarily to eyecare professionals, hospitals, clinics, and distributors rather than directly to consumers. CooperVision generates the majority of revenue through recurring contact lens sales across the Americas, Europe, and Asia-Pacific, while CooperSurgical serves fertility clinics and women's health providers, largely in the United States. The company was founded in 1958 and is headquartered in San Ramon, California.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | 2.72 | |||||
Interest Coverage | 6.1 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.83 | |||||
Beneish M-Score | -2.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.1 | |||||
3-Year EBITDA Growth Rate | 5.7 | |||||
3-Year EPS without NRI Growth Rate | 10 | |||||
3-Year FCF Growth Rate | -1.4 | |||||
3-Year Book Growth Rate | 5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 7.63 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.39 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.49 | |||||
9-Day RSI | 30.61 | |||||
14-Day RSI | 29.53 | |||||
3-1 Month Momentum % | 13.16 | |||||
6-1 Month Momentum % | 2.51 | |||||
12-1 Month Momentum % | 18.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.22 | |||||
Quick Ratio | 0.73 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 223.07 | |||||
Days Sales Outstanding | 69.37 | |||||
Days Payable | 64.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 6.72 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 65.93 | |||||
Operating Margin % | 12.84 | |||||
Net Margin % | 13.46 | |||||
EBITDA Margin % | 22.08 | |||||
FCF Margin % | 16.01 | |||||
OCF Margin % | 24.35 | |||||
ROE % | 6.87 | |||||
ROA % | 4.57 | |||||
ROIC % | 4.55 | |||||
3-Year ROIIC % | 4.54 | |||||
ROC (Joel Greenblatt) % | 18 | |||||
ROCE % | 5.02 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.49 | |||||
Forward PE Ratio | 11.56 | |||||
PE Ratio without NRI | 11.75 | |||||
Shiller PE Ratio | 14.33 | |||||
Price-to-Owner-Earnings | 18.68 | |||||
PEG Ratio | 1.09 | |||||
PS Ratio | 2.5 | |||||
PB Ratio | 1.24 | |||||
Price-to-Tangible-Book | 3.52 | |||||
Price-to-Free-Cash-Flow | 15.62 | |||||
Price-to-Operating-Cash-Flow | 10.26 | |||||
EV-to-EBIT | 23.69 | |||||
EV-to-Forward-EBIT | 14.92 | |||||
EV-to-EBITDA | 13.97 | |||||
EV-to-Forward-EBITDA | 10.54 | |||||
EV-to-Revenue | 3.08 | |||||
EV-to-Forward-Revenue | 2.92 | |||||
EV-to-FCF | 18.64 | |||||
Price-to-GF-Value | 0.59 | |||||
Price-to-Projected-FCF | 0.93 | |||||
Price-to-DCF (Earnings Based) | 0.94 | |||||
Price-to-DCF (FCF Based) | 1.39 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.21 | |||||
Price-to-Graham-Number | 1.38 | |||||
Earnings Yield (Greenblatt) % | 4.21 | |||||
FCF Yield % | 6.37 | |||||
Forward Rate of Return (Yacktman) % | 9.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
The Cooper Companies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3,639.808 | ||
| EPS (TTM) (€) | 2.534 | ||
| Beta | 0.9141 | ||
| 3-Year Sharpe Ratio | -0.34 | ||
| 3-Year Sortino Ratio | -0.45 | ||
| Volatility % | 32.5 | ||
| 14-Day RSI | 29.53 | ||
| 14-Day ATR (€) | 1.397041 | ||
| 20-Day SMA (€) | 55.11775 | ||
| 12-1 Month Momentum % | 18.65 | ||
| 52-Week Range (€) | 46.01 - 74.5 | ||
| Shares Outstanding (Mil) | 190.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
The Cooper Companies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
The Cooper Companies Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| First quarter earnings conference call for 2027 | 2027-03-05 17:00 | In 165 days | ||
| First quarter earnings results for 2027 | 2027-03-05 16:15 | In 165 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-12-04 17:00 | In 74 days | ||
| Fourth quarter earnings results for 2026 | 2026-12-04 16:15 | In 74 days | ||
| Annual report for 2026 | 2026-12-04 | In 73 days | ||
| Third quarter earnings conference call for 2026 | 2026-09-09 17:00 | 59.43 (+0.00%) | ||
| Third quarter earnings results for 2026 | 2026-09-09 16:15 | 59.43 (+0.00%) | ||
| Second quarter earnings conference call for 2026 | 2026-06-04 17:00 | 50.85 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-06-04 16:15 | 50.85 (+0.00%) | ||
| General meeting for 2026 | 2026-04-07 08:00 | 61.00 (+0.00%) |
Show
Entries
The Cooper Companies Inc Frequently Asked Questions
What is The Cooper Companies Inc(FRA:CP60)'s stock price today?
The current price of FRA:CP60 is €48.12. The 52 week high of FRA:CP60 is €74.50 and 52 week low is €46.01.
When is next earnings date of The Cooper Companies Inc(FRA:CP60)?
The next earnings date of The Cooper Companies Inc(FRA:CP60) is 2026-12-04 Est..
Does The Cooper Companies Inc(FRA:CP60) pay dividends? If so, how much?
The Cooper Companies Inc(FRA:CP60) does not pay dividend.